During the past decade, Laurent SEBBAG conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Laurent SEBBAG" are "Coronary and Peripheral Endothelial Dysfunction" (1 trials) and "Heart Transplant Failure" (1 trials). Many other conditions were trialed in "Laurent SEBBAG" in a lesser frequency.

Most popular intervention types in "Laurent SEBBAG" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Belatacept Injection" (1 trials), "Gliclazide" (1 trials) and "Metformin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Laurent SEBBAG" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Laurent SEBBAG". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Laurent SEBBAG, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Laurent SEBBAG, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".